Seeking Alpha

Royalty Pharma raises its offer for Elan (ELN +2.4%) to $12.50/share.

Royalty Pharma raises its offer for Elan (ELN +2.4%) to $12.50/share.
Comments (2)
  • bberuch
    , contributor
    Comments (264) | Send Message
     
    a step in the right direction.
    20 May 2013, 12:12 PM Reply Like
  • jdbeckerle
    , contributor
    Comments (4) | Send Message
     
    Put up or shut up time for Biogen and any other suitors. I think a 15 to 1 share swap with BIIB will be the ultimate winner.
    20 May 2013, 01:41 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|